Quantum Genesis AI (QTZM) Equity Ratio (2016 - 2026)
Quantumzyme's Equity Ratio history spans 6 years, with the latest figure at 7090.54 for Q1 2026.
- For Q1 2026, Equity Ratio changed N/A year-over-year to 7090.54; the TTM value through Jan 2026 reached 7090.54, changed N/A, while the annual FY2025 figure was 754.65, 2563.8% down from the prior year.
- Equity Ratio reached 7090.54 in Q1 2026 per QTZM's latest filing, down from 2666.22 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 28.33 in Q3 2024 to a low of 7090.54 in Q1 2026.
- Average Equity Ratio over 3 years is 2245.81, with a median of 754.65 recorded in 2025.
- The largest YoY upside for Equity Ratio was 2563.8% in 2025 against a maximum downside of 2563.8% in 2025.
- A 3-year view of Equity Ratio shows it stood at 28.33 in 2024, then plummeted by 9311.34% to 2666.22 in 2025, then crashed by 165.94% to 7090.54 in 2026.
- Per Business Quant, the three most recent readings for QTZM's Equity Ratio are 7090.54 (Q1 2026), 2666.22 (Q4 2025), and 754.65 (Q3 2025).